000 01522 a2200433 4500
005 20250516123520.0
264 0 _c20131017
008 201310s 0 0 eng d
022 _a1755-5949
024 7 _a10.1111/cns.12036
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSonali, Nirmal
245 0 0 _aClinical effectiveness of rivastigmine monotherapy and combination therapy in Alzheimer's patients.
_h[electronic resource]
260 _bCNS neuroscience & therapeutics
_cFeb 2013
300 _a91-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAlzheimer Disease
_xdrug therapy
650 0 4 _aCholinesterase Inhibitors
_xadministration & dosage
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aGene Frequency
_xgenetics
650 0 4 _aGlucuronosyltransferase
_xgenetics
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMemantine
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aPharmacogenetics
_xmethods
650 0 4 _aPhenylcarbamates
_xadministration & dosage
650 0 4 _aRivastigmine
650 0 4 _aTreatment Outcome
700 1 _aTripathi, Manjari
700 1 _aSagar, Rajesh
700 1 _aVelpandian, Thirumurthy
700 1 _aSubbiah, Vivekanandhan
773 0 _tCNS neuroscience & therapeutics
_gvol. 19
_gno. 2
_gp. 91-7
856 4 0 _uhttps://doi.org/10.1111/cns.12036
_zAvailable from publisher's website
999 _c22314345
_d22314345